We operate in between Finland, Switzerland, Japan and China.
Why internationalize with us?
Extensive international experience
Extensive international networks
Creative and innovative approach
How we work
“Commercialization via internationalization”
Tune In to Our Latest
It is a known fact that most internationalization attempts fail due to lack of thorough preparation and adhering to the chosen strategy.
When it comes to life sciences – healthcare technology, biomedical technology and pharmaceuticals – that is an industry operating in a heavily regulated environment, any attempt to seek market growth through internationalization faces a multitude of specific considerations.
Is it a good time to start an internationalization project? Perhaps this is the first question that comes to mind? Using the opposite argument: Why would it not be?
One has to keep in mind that planning an effective internationalization with a good strategy and essential activities is a longterm project that spans from a half year to several years – depending on the target market. Half a year invested in internationalization is enough to outline a strategy at its best and to get a vague understanding of the market dynamics.
The life science industry distinguishes itself from other high-technology industries with such fundamental dimensions as applying scientific knowledge to provide technological solutions aiming to improve health care and quality of life in a highly regulated environment. At the same time, usually purchasing decisions are not made by end-consumers, but their physicians or such third party as an insurance company, for example.